biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF
Cardiff Oncology
Cardiff Oncology is a biotech organization headquartered in San Diego, USA. It trades on NYSE under ticker CRDF. Primary therapeutic focus areas include Colorectal Cancer, Psoriatic Arthritis, Rheumatoid Arthritis, Acute
11055 Flintkote Avenue, San Diego, California 92121, US HQ
1999 Founded
51 Employees
Public company Type
CRDF · NYSE Ticker
Company details
- Status
- Public
- HQ
- 11055 Flintkote Avenue, San Diego, California 92121, US
- Founded
- 1999
- Employees
- 51
- Programs
- 58
- Drugs
- 62
- Patents
- 69
Synacthen (Tetracosactrin)
Approved · small molecule · Healthy
Synacthen (Tetracosactrin) for Healthy is a Approved program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Internal code SPON 431-07
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cardiff Oncology
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Healthy
- Status
- completed
- Trials
- 1